This is an investigational study. Enzalutamide is FDA approved for the treatment of certain types of prostate cancer. Paclitaxel and carboplatin are FDA approved for the treatment of ovarian cancer. The use of the combination of these 3 drugs to treat endometrial cancer is investigational.